Conference Coverage

Bloating. Flatulence. Think SIBO


 

EXPERT ANALYSIS FROM RWCS 2018

Indeed, 40% of patients will experience recurrent SIBO symptoms within 9 months after a round of rifaximin. Recurrences are more common in patients on chronic proton pump–inhibitor therapy, the elderly, and those who have undergone appendectomy. Such patients may need another course of rifaximin once or twice per year.

“If they need rifaximin every 6 months, fine. Patients will be so grateful to you for that course of rifaximin,” Dr. Mahadevan said.

Patients with methane-predominant bacterial overgrowth, as opposed to hydrogen-predominant overgrowth, often benefit from concomitant neomycin at 500 mg twice per day along with their 10-14 days of rifaximin.

“A lot of our cirrhotic patients are on both,” she noted.

Pages

Recommended Reading

Statin didn’t slow hepatic steatosis in HIV patients
MDedge Infectious Disease
Fecal microbiota transplants by oral capsule noninferior to colonoscopy
MDedge Infectious Disease
Risks identified for drug-resistant bacteremia in cirrhosis
MDedge Infectious Disease
Common food additive makes C. difficile more virulent
MDedge Infectious Disease
CMV colitis mortality rates similar in both immunocompetent and immunocompromised patients
MDedge Infectious Disease
FDA issues safety alert for loperamide
MDedge Infectious Disease
Duodenoscope redesign prompts voluntary recall by Pentax
MDedge Infectious Disease
New C. difficile guidelines recommend fecal microbiota transplants
MDedge Infectious Disease
Newborn oral rotavirus vaccine held effective
MDedge Infectious Disease
NASH rapidly overtaking hepatitis C as cause of liver cancer
MDedge Infectious Disease